Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial
Top Cited Papers
- 1 December 2000
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 356 (9247) , 2059-2063
- https://doi.org/10.1016/s0140-6736(00)03403-6
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluationPublished by Elsevier ,2002
- Oral Clonidine in Postmenopausal Patients with Breast Cancer Experiencing Tamoxifen-Induced Hot Flashes: A University of Rochester Cancer Center Community Clinical Oncology Program StudyAnnals of Internal Medicine, 2000
- Evaluation of Soy Phytoestrogens for the Treatment of Hot Flashes in Breast Cancer Survivors: A North Central Cancer Treatment Group TrialJournal of Clinical Oncology, 2000
- PILOT EVALUATION OF VENLAFAXINE FOR THE TREATMENT OF HOT FLASHES IN MEN UNDERGOING ANDROGEN ABLATION THERAPY FOR PROSTATE CANCERJournal of Urology, 1999
- Definitions of Hot Flashes in Breast Cancer SurvivorsJournal of Pain and Symptom Management, 1998
- Linking Clinical Variables With Health-Related Quality of LifeJAMA, 1995
- Megestrol Acetate for the Prevention of Hot FlashesNew England Journal of Medicine, 1994
- Estrogen Replacement Therapy in Women with Breast Cancer: A Survey of Patient AttitudesThe Lancet Healthy Longevity, 1992
- Effect of Bellergal Retard on climacteric complaints: a double-blind, placebo-controlled studyMaturitas, 1987
- Reduction of menopausal hot flushes by methyldopaEuropean Journal of Clinical Pharmacology, 1981